je.st
news
Tag: medicine
Nonprescription Nexium heartburn medicine launches
2014-05-29 06:40:01| Biotech - Topix.net
Drugmaker Pfizer Inc. said Tuesday that over-the-counter Nexium 24HR is available for online orders at www.Nexium24HR.com and will be in most retailers nationwide within three days.
Tags: medicine
launches
heartburn
nonprescription
Nonprescription Nexium Heartburn Medicine Launches
2014-05-27 20:18:27| Biotech - Topix.net
Drugmaker Pfizer Inc. says over-the-counter Nexium 24HR is available for online orders at www.Nexium24HR.com and will be on shelves in most retailers nationwide within three days.
Tags: medicine
launches
heartburn
nonprescription
3 Wild Ways the Animal Kingdom is Advancing Medicine and Public Health
2014-05-25 19:25:08| Biotech - Topix.net
Most people are aware that various agricultural crops have been engineered to increase the production benefits for farmers .
Tags: public
health
kingdom
ways
Inhaler Dose Counter keeps track of remaining medicine.
2014-05-13 14:30:47| Industrial Newsroom - All News for Today
Single Dose Counter, which lets PMDI (pressurized metered dose inhaler) users countdown number of doses taken, has 999-count range. Product can also be pre-set to count any specific number in-between, as in counting down from 200 or 120 to 0, allowing users to keep track of medication and alerting them when inhaler is nearing its useful end. Able to be retrofitted to all types of standard mouthpieces with minor modifications, product features 7-part construction. This story is related to the following:Material Handling and Storage Sponsored by: Dalmec Inc - Tile AdSearch for suppliers of: Counters |
Tags: track
counter
medicine
remaining
AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients
2014-05-08 15:00:00| Merck.com - Research & Development News
Dateline City: WUPPERTAL, Germany & WHITEHOUSE STATION, N.J. WUPPERTAL, Germany & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--AiCuris and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical trial evaluating the safety and efficacy of letermovir, an investigational, oral antiviral agent for the prevention of human cytomegalovirus (CMV) infection in patients receiving bone marrow transplant. Language: English Contact: MerckMedia:Caroline Lappetito, 267-305-7639orInvestors:Carol Ferguson, 908-423-4465orAiCurisMedia:Katja Woestenhemke, +49-202-317-63-1176 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
publication
journal
agent
Sites : [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] next »